Request Free Sample ×
Pain Management Devices Market-Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Pain management devices Market

ID: MRFR/HC/0975-HCR
200 Pages
Nidhi Mandole, Rahul Gotadki
Last Updated: May 14, 2026
Pain Management Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Stimulators, Analgesics Delivery Devices, Cryotherapy Devices, Radiofrequency Ablation Devices), By Therapeutic Area (Chronic Pain, Acute Pain, Postoperative Pain, Cancer Pain), By End Users (Hospitals, Home Care Settings, Ambulatory Surgical Centers, Physical Therapy Clinics), By Technology (Transcutaneous Electrical Nerve Stimulator, Intrathecal Drug Delivery Systems, Cryoablation Technology, Radiofrequency Technology) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast Till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Pain management devices Market Infographic
Summary Table of Contents Segmentation Methodology Download PDF

Pain management devices Market Summary

The Global Pain Management Devices Market size was valued at USD 6.57 Billion in 2024, and the market is projected to grow from USD 6.94 Billion in 2025 to USD 12.0 Billion by 2035, registering a CAGR of 5.63% during the forecast period 2026–2035. North America led the market in 2024 with over 45.66% share, generating around USD 3.0 Billion in revenue.
 
The increasing global burden of chronic pain and rising preference for minimally invasive therapies are major growth factors driving the global market. Growing adoption of neuromodulation technologies, wearable pain relief devices, and advanced rehabilitation systems is improving patient outcomes and accelerating market expansion worldwide.
 
According to the World Health Organization (WHO), approximately 1.71 billion people globally suffer from musculoskeletal conditions, one of the leading causes of chronic pain and disability. Additionally, the CDC estimates that nearly 51.6 million U.S. adults experience chronic pain annually, significantly increasing demand for advanced pain management devices and non-opioid treatment solutions.

Key Market Trends & Highlights

The Pain Management Devices Market is experiencing robust growth driven by technological advancements and increasing demand for personalized treatment solutions.

  • Stimulators dominated the device type segment with approximately 63% share in 2024 due to strong neuromodulation therapy adoption globally.
  • Chronic pain therapeutic applications accounted for nearly 68% market share, supported by increasing arthritis and musculoskeletal disorder prevalence worldwide.
  • North America accounted for over 45.66% global market revenue in 2024, supported by advanced healthcare infrastructure and chronic pain prevalence.
  • Europe market reached USD 1.97 billion in 2024, representing nearly 30% global market share regionally.

Market Size & Forecast

2024 Market Size 6.57 (USD Billion)
2035 Market Size 12.0 (USD Billion)
CAGR (2025 - 2035) 5.63%

Major Players

Companies such as Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Johnson & Johnson (US), Stryker Corporation (US), NeuroMetrix (US), Halyard Health (US), Cymedica Orthopedics (US), Bioness (US) are some of the major participants in the global market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Pain management devices Market Trends

The Pain Management Devices Market is currently experiencing a notable evolution, driven by advancements in technology and an increasing awareness of chronic pain conditions. As healthcare systems worldwide strive to enhance patient outcomes, there is a growing emphasis on non-invasive and drug-free solutions. This shift is likely to foster innovation in device design and functionality, catering to a diverse range of pain management needs.

Furthermore, the integration of digital health technologies, such as telemedicine and mobile applications, appears to be reshaping how patients access and utilize pain management devices. In addition, the global market is witnessing a surge in demand for personalized treatment options. Patients are increasingly seeking tailored solutions that address their specific pain profiles, which may lead to the development of more sophisticated devices. 

This trend suggests a potential shift towards a more patient-centric approach in pain management, where devices are not only effective but also adaptable to individual requirements. As the pain management market continues to evolve, stakeholders must remain vigilant to emerging trends and consumer preferences to ensure they meet the changing landscape of pain management effectively.

Technological Advancements

The global market is seeing rapid technological progress, with innovations such as wearable devices and smart pain relief solutions. These advancements enhance user experience and improve treatment efficacy, making pain management more accessible.

The increasing adoption of wearable healthcare technologies and smart therapeutic systems is significantly supporting technological advancements in pain management devices. According to the World Health Organization (WHO), digital health interventions are improving healthcare accessibility for billions globally, while the CDC reports rising utilization of non-invasive pain therapies among chronic pain patients.

Continuous innovation in neuromodulation, wearable stimulators, and AI-enabled monitoring systems is enhancing treatment precision, patient mobility, and long-term pain management outcomes across healthcare facilities and homecare environments.

Personalized Treatment Approaches

There is a growing trend towards personalized pain management solutions, as patients increasingly seek devices tailored to their unique pain experiences. This shift may lead to the development of customizable devices that cater to individual needs.

  • The growing prevalence of chronic diseases and patient-specific therapy demand is accelerating personalized treatment approaches in pain management. According to the Institute for Health Metrics and Evaluation (IHME), chronic pain-related disorders contribute substantially to years lived with disability globally. Increasing integration of patient-centric neuromodulation devices, customized stimulation settings, and targeted analgesic delivery systems is improving treatment efficiency, reducing adverse effects, and supporting individualized pain relief solutions for aging populations and long-term care patients.

Integration of Digital Health Solutions

The incorporation of digital health technologies into the global market is transforming patient engagement. Telehealth platforms and mobile applications are facilitating remote monitoring and support, enhancing the overall management of pain.

  • The integration of telehealth and mobile health technologies is strengthening digital pain management solutions globally. According to the Pan American Health Organization (PAHO), telehealth adoption across healthcare systems expanded considerably following increased remote care demand, improving access to chronic disease management services. Digital pain monitoring applications, connected wearable devices, and remote therapy platforms are enhancing patient engagement, treatment adherence, and continuous pain assessment, particularly among elderly and mobility-restricted populations.

Pain management devices Market Drivers

Aging Population

The aging population is another critical factor influencing the Pain Management Devices Market. As individuals age, they often experience an increase in chronic pain conditions, including arthritis and degenerative diseases. The demographic shift towards an older population is expected to drive demand for pain management solutions. By 2030, it is anticipated that the number of individuals aged 65 and older will reach approximately 1.5 billion, creating a substantial market for pain management devices.
 
This demographic trend suggests that healthcare systems will increasingly rely on advanced pain management technologies to address the needs of older patients. Consequently, the global industry is likely to witness significant growth as manufacturers develop devices tailored to the unique requirements of this demographic.

Rising Healthcare Expenditure

Rising healthcare expenditure is a significant driver for the Pain Management Devices Market. As countries invest more in healthcare infrastructure and services, there is an increasing focus on pain management solutions. This trend is particularly evident in regions where healthcare systems are evolving to prioritize patient-centered care.
 
Increased funding for pain management programs and devices is likely to enhance accessibility and affordability for patients. Furthermore, as healthcare providers recognize the importance of effective pain management in improving patient outcomes, the demand for pain management devices is expected to rise. The global industry stands to benefit from this trend, as higher healthcare expenditure translates into greater investment in innovative pain management technologies.

Rising Prevalence of Chronic Pain

The increasing prevalence of chronic pain conditions is a primary driver for the Pain Management Devices Market. Conditions such as arthritis, fibromyalgia, and neuropathic pain affect millions of individuals worldwide. According to recent estimates, nearly 20% of adults experience chronic pain, which necessitates effective pain management solutions.
 
This growing patient population is likely to propel demand for innovative pain management devices, as healthcare providers seek to offer effective treatments. The global market is expected to expand significantly as a result, with projections indicating a compound annual growth rate of over 8% in the coming years. As more patients seek relief from chronic pain, the global market for devices designed to alleviate discomfort is poised for substantial growth.

Technological Innovations in Pain Management Devices

Technological innovations are transforming the Pain Management Devices Market, leading to the development of more effective and user-friendly devices. Advancements in areas such as neuromodulation, wearable technology, and telehealth are enhancing the capabilities of pain management devices. For instance, devices that utilize electrical stimulation or biofeedback mechanisms are becoming increasingly popular due to their non-invasive nature and effectiveness.
 
The integration of smart technology allows for real-time monitoring and personalized treatment plans, which may improve patient outcomes. As these innovations continue to emerge, the global industry is likely to experience robust growth, driven by the demand for cutting-edge solutions that cater to diverse patient needs.

Increased Awareness and Acceptance of Pain Management Solutions

There is a growing awareness and acceptance of pain management solutions among both healthcare providers and patients, which serves as a significant driver for the Pain Management Devices Market. Educational initiatives and advocacy efforts have contributed to a better understanding of chronic pain and its impact on quality of life.
 
As a result, patients are more likely to seek out effective pain management options, including devices that offer non-invasive or minimally invasive treatments. This shift in perception is likely to enhance the global market landscape, with an increasing number of healthcare professionals recommending pain management devices as part of comprehensive treatment plans. The global industry is expected to benefit from this trend, as more patients embrace innovative solutions to manage their pain.

Market Segment Insights

By Device Type: Stimulators (Largest) vs. Analgesics Delivery Devices (Fastest-Growing)

In the Pain Management Devices Market, stimulators hold the largest share, accounting for 63% among device types, showcasing their critical role in managing chronic pain through neuromodulation techniques. Analgesics delivery devices are also gaining traction due to their effectiveness in delivering medication directly to target areas, thus reducing systemic side effects and enhancing patient compliance.

Stimulators (Dominant) vs. Analgesics Delivery Devices (Emerging)

Stimulators are currently the dominant force in the pain management landscape, known for their ability to provide targeted pain relief through methods such as spinal cord stimulation and transcutaneous electrical nerve stimulation (TENS). Conversely, analgesics delivery devices represent an emerging segment, characterized by innovative solutions such as patient-controlled analgesia and implantable delivery systems. These devices are rapidly evolving in response to the demand for personalized pain management strategies, highlighting their potential to revolutionize patient care by ensuring timely and effective medication delivery.

By Therapeutic Area: Chronic Pain (Largest) vs. Cancer Pain (Fastest-Growing)

In the Pain Management Devices Market, chronic pain holds the largest share at 68%, representing a significant portion of current demand. Chronic pain conditions often require ongoing management, leading to a consistent need for advanced therapeutic devices. In contrast, cancer pain, while currently smaller in market share, is experiencing rapid growth as advancements in cancer treatments and rising survival rates increase the need for effective pain management solutions. Market growth trends indicate that the demand for devices addressing chronic pain remains strong, as more individuals seek relief from conditions such as arthritis and back pain. Meanwhile, the emergence of innovative devices specifically designed for cancer pain management is revolutionizing this segment, driven by an aging population and increasing incidences of cancer, highlighting the need for tailored pain management options.

Chronic Pain: Dominant vs. Cancer Pain: Emerging

Chronic pain is characterized by prolonged discomfort, often linked to various conditions, including arthritis, fibromyalgia, and neuropathy. It is the dominant segment in the global market due to the extensive patient population requiring continuous relief. Treatments in this segment are well-established, utilizing devices like TENS units and spinal cord stimulators. Conversely, cancer pain is emerging as a critical focus for innovation in pain management. This segment involves complex pain syndromes that necessitate specialized devices to provide targeted relief. The rise of personalized medicine approaches allows for more effective management of cancer pain, enhancing patient quality of life and fostering the development of groundbreaking treatment modalities.

By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

The Pain Management Devices Market is primarily characterized by significant contributions from various end users including hospitals, home care settings, ambulatory surgical centers, and physical therapy clinics. Among these, hospitals hold the largest share, 52%, in the pain management market due to their extensive resources and patient bases, allowing for a wide range of pain management solutions. Home care settings are gaining traction as a valid segment, indicating a shift in consumer preferences towards at-home management of pain, given the convenience and cost-effectiveness associated with personal care environments.

Hospitals (Dominant) vs. Home Care Settings (Emerging)

Hospitals serve as the dominant end user within the market, leveraging state-of-the-art technology alongside comprehensive healthcare services. They are equipped with specialized staff and facilities that cater to complex pain management needs, driving the demand for advanced devices. Conversely, home care settings are emerging as a promising segment, reflecting a paradigm shift towards at-home treatment modalities. This growth is driven by an aging population and increasing chronic pain prevalence, coupled with technological advancements that facilitate effective remote pain management. Together, they embody a dynamic contrast between established practices and modern, home-based solutions.

By Technology: Transcutaneous Electrical Nerve Stimulator (Largest) vs. Intrathecal Drug Delivery Systems (Fastest-Growing)

The Pain Management Devices Market is witnessing a diverse distribution of technologies, with the Transcutaneous Electrical Nerve Stimulator (TENS) leading in market share of 41%, due to its widespread acceptance and ease of use. In contrast, Intrathecal Drug Delivery Systems are rapidly gaining traction, capturing the attention of healthcare providers and patients alike, as they provide targeted pain relief with fewer systemic side effects compared to traditional methods. The remaining technologies such as Cryoablation and Radiofrequency are also essential but currently represent smaller market portions.

Technology: TENS (Dominant) vs. Intrathecal Drug Delivery Systems (Emerging)

Transcutaneous Electrical Nerve Stimulators (TENS) remain the dominant force in the global market, primarily due to their user-friendly application for chronic pain relief, making them highly accessible for patients. Meanwhile, Intrathecal Drug Delivery Systems are emerging as a promising alternative, especially for patients unresponsive to conventional therapies. These systems allow for localized drug delivery directly to the spinal cord, minimizing side effects associated with oral or intravenous medications. As chronic pain management evolves, the intrinsic safety profile and efficacy of these technologies propel them closer to prominence in clinical practices. The competition among these technologies indicates a growing inclination towards patient-centered approaches in pain management.

Get more detailed insights about Pain management devices Market
Request Free Sample

Regional Insights

The Pain Management Devices Market showcases significant regional variations in its dynamics and performance. In 2024, North America dominates the market with a valuation of 2.7 USD Billion, expected to grow to 4.8 USD billion by 2035, primarily due to advanced healthcare infrastructure and increased demand for innovative pain management solutions.

  • According to the CDC, nearly 20.9% of U.S. adults experienced chronic pain in recent years, creating substantial demand for advanced pain management therapies and medical devices. Additionally, the region maintains strong healthcare expenditure levels and rapid adoption of minimally invasive technologies, supporting continued growth of wearable stimulators, neurostimulation systems, and home-based pain management solutions throughout North America.

Europe follows closely with a market valuation of 2.1 USD Billion in 2024, projected to reach 3.7 USD billion by 2035, driven by a growing aging population and rising prevalence of chronic pain conditions.South America, while smaller, is also making strides with valuations of 0.5 USD Billion in 2024, forecasting to hit 1.0 USD billion in 2035, indicating a significant growth potential in response to improving healthcare access.

  • According to the World Health Organization (WHO), musculoskeletal conditions are among the leading contributors to disability across Europe, significantly impacting aging populations. Increasing healthcare investments, rising chronic pain cases, and broader adoption of digital healthcare technologies are accelerating demand for neuromodulation devices, rehabilitation equipment, and advanced pain relief systems throughout the European healthcare sector.

The Asia Pacific region holds a notable position with a valuation of 1.8 USD billion expected to increase to 2.8 USD billion by 2035, reflecting a growing focus on pain management due to increasing incidences of lifestyle-related ailments. Lastly, the Middle East and Africa, valued at 0.47 USD billion in 2024 and expected to reach 0.7 USD billion by 2035, exhibit a developing market with efforts to strengthen healthcare sectors.Overall, the market segmentation reveals varied growth trajectories, where North America leads the majority holding, while other regions present unique opportunities that could shape future market trends.

Pain management devices Market Regional Image

Key Players and Competitive Insights

The Pain Management Devices Market is characterized by rapid advancements in technology coupled with an increasing prevalence of chronic pain conditions, which significantly drives competition among key players. This market is witnessing a surge in demand for innovative and effective pain management solutions, thereby prompting medical device manufacturers to invest heavily in research and development.
 
The competitive landscape is marked by a diverse range of pain management device companies, each vying to develop cutting-edge devices that cater to the varying needs of patients. As medical device manufacturers strive to differentiate their offerings, market participants are focusing on enhancing product efficacy, improving user experience, and expanding geographical reach.
 
The overarching trends include the integration of digital technologies in pain management solutions and a growing emphasis on minimally invasive devices. Nuvectra has established itself as a noteworthy player within the Pain Management Devices Market, primarily through its commitment to innovative solutions tailored for chronic pain management. The company is known for developing advanced neuromodulation devices that target specific pain pathways, thereby offering patients personalized and effective treatment options.
 
Nuvectra's strength lies in its robust research capabilities, which enable it to stay ahead of market trends and develop products that respond to the evolving needs of healthcare practitioners and patients alike. The company's strategic focus on partnerships with healthcare providers and effective clinician training further enhances its market presence, positioning it favorably among competitors in the ever-evolving pain management landscape.Bayer AG holds a significant position in the global market, driven by its broad portfolio of healthcare solutions aimed at pain relief.
 
The company is known for its commitment to providing comprehensive pain management through a combination of pharmaceutical and device-based therapies. Key products include a range of analgesics and innovative medical devices designed to alleviate pain, thereby addressing a critical aspect of patient care. Bayer AG's strengths are further amplified by its extensive research and development investments, which consistently lead to the introduction of novel products that meet high clinical standards.
 
The company's strategic approach includes forming alliances and considering mergers and acquisitions to refine its product offering and expand its global footprint. This positions Bayer AG as a key contender in the global market, catering to the complex needs of patients and healthcare providers in the realm of pain management globally.

Key Companies in the Pain management devices Market include

Industry Developments

Recent changes in the Pain Management Devices Market show that there is more innovation and strategic partnerships to help people deal with chronic pain better. In September 2023, Medtronic added to its neuromodulation line by releasing a wireless spinal cord stimulator. This device is meant to give patients more control and improve treatment outcomes. Also, in August 2023, Stryker Corporation and NeuroMetrix, a company that makes wearable pain therapy devices, signed a deal to work together to make solutions for managing chronic pain.

Boston Scientific bought Relievant Medical Systems in November 2023, which improved its ability to treat vertebrogenic back pain. The market has been steadily growing since 2021, thanks to the rising demand for minimally invasive and non-opioid options for chronic pain. This is especially true for neuromodulation technologies like TENS units, radiofrequency ablation, and peripheral nerve stimulators. 

Medical device manufacturers like Abbott Laboratories, which is a major player in spinal cord stimulation, and Zynex Medical, which makes FDA-approved electrotherapy devices, are still putting more money into research and development.

The goal of these efforts is to make things more effective, comfortable for patients, and easy to program from a distance. Overall, the Pain Management Devices Industry is on a strong upward trend because of new technologies and more people using them in clinical settings.

Future Outlook

Pain management devices Market Future Outlook

The Pain Management Devices Market size is projected to reach USD 12.0 Billion by 2035, growing at a CAGR of 5.63%, driven by technological advancements, increasing chronic pain prevalence, and rising healthcare expenditure.

New opportunities lie in:

  • Development of portable pain relief devices for home use. Integration of AI for personalized pain management solutions. Expansion into emerging markets with tailored product offerings.

By 2035, the global market is expected to be robust, driven by innovation and strategic expansions.

Market Segmentation

Pain management devices Market End User Outlook

  • Hospitals
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Physical Therapy Clinics

Pain management devices Market Technology Outlook

  • Transcutaneous Electrical Nerve Stimulator
  • Intrathecal Drug Delivery Systems
  • Cryoablation Technology
  • Radiofrequency Technology

Pain management devices Market Device Type Outlook

  • Stimulators
  • Analgesics Delivery Devices
  • Cryotherapy Devices
  • Radiofrequency Ablation Devices

Pain management devices Market Therapeutic Area Outlook

  • Chronic Pain
  • Acute Pain
  • Postoperative Pain
  • Cancer Pain

Report Scope

MARKET SIZE 2024 6.57(USD Billion)
MARKET SIZE 2025 6.94(USD Billion)
MARKET SIZE 2035 12.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.63% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2026 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Johnson & Johnson (US), Stryker Corporation (US), NeuroMetrix (US), Halyard Health (US), Cymedica Orthopedics (US), Bioness (US)
Segments Covered Device Type, Therapeutic Area, End Users, Technology, Regional
Key Market Opportunities Integration of wearable technology enhances patient engagement in the Pain Management Devices Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Pain Management Devices Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the market by 2035?

The market is projected to reach a valuation of 12.0 USD Billion by 2035.

What was the market valuation of the market in 2024?

In 2024, the market valuation of Pain Management Devices was 6.57 USD Billion.

What is the expected CAGR for the market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 5.63%.

Which companies are considered key players in the market?

Key players in the market include Medtronic, Boston Scientific, Abbott Laboratories, Johnson & Johnson, and Stryker Corporation.

What are the main segments of the market?

The main segments of the market include Device Type, Therapeutic Area, End User, and Technology.

How much is the market for Stimulators expected to grow by 2035?

The market for Stimulators is expected to grow from 2.0 USD Billion in 2024 to 3.5 USD Billion by 2035.

What is the projected growth for Analgesics Delivery Devices by 2035?

Analgesics Delivery Devices are projected to grow from 2.5 USD Billion in 2024 to 4.0 USD Billion by 2035.

What is the expected market size for Cancer Pain management devices by 2035?

The market size for Cancer Pain management devices is expected to increase from 2.07 USD Billion in 2024 to 4.0 USD Billion by 2035.

Which end user segment is anticipated to have the highest growth by 2035?

The Physical Therapy Clinics segment is anticipated to grow from 2.07 USD Billion in 2024 to 4.0 USD Billion by 2035.

What technological advancements are expected to influence the Pain Management Devices Market?

Technological advancements such as Radiofrequency Technology and Intrathecal Drug Delivery Systems are expected to significantly influence the market, with projected growth to 4.0 USD Billion by 2035.

Author
Author
Author Profile
Nidhi Mandole LinkedIn
Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed clinical journals, medical device registries, and authoritative health organizations specific to interventional pain management and neuromodulation therapies. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) and the Global Unique Device Identification Database (GUDID), European Medicines Agency (EMA) Medical Device Coordination Group, Therapeutic Goods Administration (TGA) Australia, Pharmaceuticals and Medical Devices Agency (PMDA) Japan, and National Medical Products Administration (NMPA) China. Clinical and epidemiological data were sourced from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS), Centers for Disease Control and Prevention (CDC) National Center for Health Statistics Chronic Pain Surveillance, Agency for Healthcare Research and Quality (AHRQ) Healthcare Cost and Utilization Project (HCUP), and World Health Organization (WHO) International Classification of Diseases (ICD-11) chronic pain classifications. Professional medical societies provided procedural standards and adoption data, including the International Association for the Study of Pain (IASP), American Academy of Pain Medicine (AAPM), North American Neuromodulation Society (NANS), International Neuromodulation Society (INS), American Society of Interventional Pain Physicians (ASIPP), American Society of Regional Anesthesia and Pain Medicine (ASRA), and European Pain Federation (EFIC). Reimbursement and policy research utilized Centers for Medicare & Medicaid Services (CMS) National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs), private payer medical policies, and health economic evaluations from the National Center for Biotechnology Information (NCBI)/PubMed and ClinicalTrials.gov. These sources were used to collect device safety surveillance data, chronic pain epidemiology statistics, neuromodulation procedure volumes, regulatory clearance trajectories, and competitive product pipelines for spinal cord stimulators, peripheral nerve stimulators, transcutaneous electrical nerve stimulation (TENS) units, implantable infusion pumps, radiofrequency ablation generators and cannulas, and cryotherapy/ultrasound pain relief devices.

 

Primary Research

As part of the main research process, stakeholders from both the supply and demand sides were interviewed to get both qualitative and quantitative information about device development roadmaps, clinical trial endpoints, and post-market surveillance outcomes. CEOs, Vice Presidents of R&D, directors of regulatory affairs, and marketing heads from neuromodulation device makers, infusion pump OEMs, and RF ablation technology providers were some of the supply-side sources. Board-certified pain management specialists, anesthesiologists, interventional radiologists, orthopedic surgeons, neurosurgeons, medical directors of ambulatory surgery centers (ASCs) and pain clinics, and procurement officers from hospitals and specialty pain treatment centers were some of the sources of demand. For both acute and chronic pain applications, primary research supported market segmentation and FDA PMA and 510(k) clearance timelines. It also found barriers to clinical adoption, changes in reimbursement coding (CPT analysis), and trends in ASP erosion.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (35%), Others (33%)

By Region: North America (40%), Europe (25%), Asia-Pacific (28%), Rest of World (7%)

 

Market Size Estimation

Global market valuation was derived through device shipment tracking, implant procedural data, and manufacturer revenue reconciliation across implantable and non-implantable pain management modalities. The methodology included:

Identification of 60+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America specializing in neuromodulation, infusion therapy, and ablation technologies

Product mapping across neurostimulation devices (spinal cord stimulators, peripheral nerve stimulators, dorsal root ganglion stimulators, TENS units), intrathecal infusion pumps, radiofrequency ablation generators and consumables, cryotherapy systems, and therapeutic ultrasound devices

Analysis of reported and modeled annual revenues specific to pain management device portfolios, including neuromodulation systems, refillable implantable pumps, and disposable RF cannulas/electrodes

Coverage of manufacturers representing 70-75% of global market share in 2024, with particular emphasis on major neuromodulation conglomerates and specialized RF ablation players

Extrapolation using bottom-up (implant volumes × device ASP by country; procedure counts for RF ablation, SCS trials, and pump refills) and top-down (publicly reported segment revenues for major medtech conglomerates) approaches to derive segment-specific valuations for implantable electrical stimulators, external TENS devices, infusion therapy systems, and thermal/ablation modalities

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035